GLUE Competitors & Alternatives
Compare Monte Rosa Therapeutics Inc with similar stocks in the same industry
Biotechnology
GLUE
Main Stock$10.31
Tradestie Score
43
Market Cap
$463.20M
Revenue Growth
3.3%
Analyst Upside
+146.1%
Top Competitors
216 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RLAY
Relay Therapeutics, Inc. Common Stock
|
$19.72
|
$917.23M | - | 44 | Compare |
|
BCAX
Bicara Therapeutics Inc. Common Stock
|
$10.53
|
$906.29M | - | 51 | Compare |
|
NBTX
Nanobiotix S.A. American Depositary Shares
|
$32.95
|
$903.54M | - | 23 | Compare |
|
ORKA
Oruka Therapeutics, Inc. Common Stock
|
$107.17
|
$900.91M | - | 33 | Compare |
|
GERN
Geron Corp
|
$1.02
|
$899.60M | - | 63 | Compare |
|
ANAB
AnaptysBio, Inc. Common Stock
|
$48.77
|
$894.30M | - | 52 | Compare |
|
TNGX
Tango Therapeutics, Inc.
|
$25.73
|
$887.30M | - | 42 | Compare |
|
ABUS
Arbutus Biopharma Corporation Common Stock
|
$3.88
|
$879.90M | 3.4 | 56 | Compare |
|
DNA
Ginkgo Bioworks Holdings, Inc.
|
$10.25
|
$868.46M | - | 48 | Compare |
|
TSHA
Taysha Gene Therapies, Inc. Common Stock
|
$4.28
|
$867.49M | - | 46 | Compare |
More GLUE Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2836)
216 stocks in this industry